Irish patients not getting access to new medicines quickly enough says IPHA

The pharmaceutical industry claims that Irish patients are not getting access to new medicines quickly enough.

The Irish Pharmaceutical Healthcare Association says Ireland has the worst record in Europe when it comes to adopting new drugs.

The IPHA is discussing the issue at its annual conference today in Dublin.

Phillip Hannon from the IPHA says the method for deciding which drugs will be funded through by the HSE is too slow.

He said: "It is the processes that we have in terms of the reimbursement periods, the processs are wrong and I think need to be looked at.

"The minister himself said on the record in the Dail that the reimbursement system is broken."


Related Articles

Alzheimer’s disease inspired family business

Irish study shows ’substantial’ health benefits from eggs and chicken enriched with Omega 3

911 fewer patients on trolleys compared to this time last year

Some 7-8 year-olds spending 21 hours a week on 'screens'; one fifth are overweight

More in this Section

Gardaí enter Galway house after reports of man barricaded inside

Ibrahim Halawa finding it difficult to adapt to his new freedom

Varadkar refuses to withdraw invite to President Trump

Government not looking at laptop levy to replace TV licence, says Naughten


Today's Stories

Tánaiste fighting for her political life

Mixed reaction to State’s €30m loan to An Post

Nursing initiative to boost services

Golden rules for online shopping safety

Lifestyle

Toy story: 10 toys guaranteed to bring out the kid in all of us

GameTech: Star Wars Battlefront II: Chance to win Loot Skywalker

Military top brass: Meet the conductor of the army’s Southern Brigade band

Album review: Experience counts on U2’s return to form

More From The Irish Examiner